Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.68 |
| ▸ | CDC25A | P30304 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.65 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696592 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL9626594 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL10731237 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL6050334 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL10725536 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL23731163 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL8863090 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL8862943 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL8863074 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL31406188 | 1.00 | CES1 (0.68) | CES1CDC25AALDH1A1ALDH2ALDH3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1967573-B1 | REFRIGERATOR OIL COMPOSITION, AND ITS USE IN REFRIGERATOR COMPRESSORS | IDEMITSU KOSAN CO (JP) | 2015-09-16 | — | — | EP | claimed |
| CN-101341234-B | Refrigerating machine oil composition, and compressor and refrigerating apparatus for refrigerator using same | IDEMITSU KOSAN CO | 2012-12-05 | — | — | CN | claimed |
| US-8137577-B2 | Refrigerator oil composition, and refrigerator compressor and refrigeration system using the composition | IDEMITSU KOSAN CO., LTD. (JP) | 2012-03-20 | — | — | US | claimed |
| CN-112105360-B | BCL-2 protein degrading agent for cancer treatment | 生物风险投资有限责任公司 | 2024-01-30 | — | — | CN | disclosed |
| WO-2023218409-A1 | PHTHALIMIDE FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2023-11-16 | — | — | WO | disclosed |
| US-20230339929-A1 | THERAPEUTIC AGENTS AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-10-26 | — | — | US | disclosed |
| CN-115038697-A | Therapeutic agents and methods of treatment | 佛罗里达大学研究基金公司 | 2022-09-09 | — | — | CN | disclosed |
| US-20220169628-A1 | THERAPEUTIC AGENTS AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2022-06-02 | — | — | US | disclosed |
| EP-3920923-A2 | THERAPEUTIC AGENTS AND METHODS OF TREATMENT | University of Florida Research Foundation, Incorporated (US) | 2021-12-15 | — | — | EP | disclosed |
| CN-113660937-A | Therapeutic agents and methods of treatment | 佛罗里达大学研究基金公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-112105360-A | BCL-2 protein degrading agents for cancer treatment | 生物风险投资有限责任公司 | 2020-12-18 | — | — | CN | disclosed |
| US-20090277212-A1 | REFRIGERATOR OIL COMPOSITION, AND REFRIGERATOR COMPRESSOR AND REFRIGERATION SYSTEM USING THE COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| CN-101341234-A | Refrigerating machine oil composition, and compressor and refrigerating apparatus for refrigerator using same | IDEMITSU KOSAN CO (JP) | 2009-01-07 | — | — | CN | disclosed |
| EP-1967573-A1 | REFRIGERATOR OIL COMPOSITION, AND REFRIGERATOR COMPRESSOR AND REFRIGERATION SYSTEM USING THE COMPOSITION | Idemitsu Kosan Co., Ltd. (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-5674864-A | ANALGESICS; ENDOPEPTIDASE AND ENKEPHALINASE INHIBITORS; CARDIOTONIC, PSYCHOTROPIC AND HYPERTENSIVE AGENTS | ROUSSEL UCLAF (FR) | 1997-10-07 | — | — | US | disclosed |
| US-5605745-A | HEATING TO CURE EPOXY RESIN WITH THERMOPLASTIC PARTICLES | CYTEC TECHNOLOGY CORP. (US) | 1997-02-25 | — | — | US | disclosed |
| EP-0377194-B1 | Toughened thermosetting structural materials | CYTEC TECH CORP (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5242748-A | Kincreasing the toughtness of a curable epoxy resin by adding a soluble or swellable thermoplastic polyimide which is fusible at resin curing temperature | BASF AKTIENGESELLSCHAFT (DE) | 1993-09-07 | — | — | US | disclosed |
| EP-0392348-A2 | Toughened thermosetting structural materials | CYTEC TECHNOLOGY CORP. (US) | 1990-10-17 | — | — | EP | disclosed |
| EP-0377194-A2 | Toughened thermosetting structural materials | CYTEC TECHNOLOGY CORP. (US) | 1990-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339929-A1 | THERAPEUTIC AGENTS AND METHODS OF TREATMENT | SLC10A1, HDGF, NHERF1 | CES1 224/4885CDC25A 252/4885ALDH1A1 430/4885 |
| US-20220169628-A1 | THERAPEUTIC AGENTS AND METHODS OF TREATMENT | HDGF, NFATC1, HGF | CES1 872/4885CDC25A 398/4885ALDH1A1 737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.